Gradient Capital Advisors’s iShares iBonds Dec 2034 Term Corporate ETF IBDZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$508K Buy
19,518
+1,532
+9% +$39.9K 0.12% 109
2026
Q1
$469K Hold
17,986
0.12% 110
2025
Q4
$474K Buy
17,986
+1,139
+7% +$30.1K 0.12% 108
2025
Q3
$446K Buy
16,847
+1,688
+11% +$44.2K 0.12% 108
2025
Q2
$396K Buy
15,159
+3,691
+32% +$94.3K 0.12% 112
2025
Q1
$296K Buy
11,468
+1,545
+16% +$39.5K 0.1% 127
2024
Q4
$253K Buy
9,923
+2,288
+30% +$59.3K 0.08% 136
2024
Q3
$204K Buy
+7,635
New +$200K 0.07% 147

Other funds holding IBDZ

Gradient Capital Advisors's IBDZ Position: Q2 2026 in Review

Gradient Capital Advisors increased its iShares iBonds Dec 2034 Term Corporate ETF (IBDZ) stake by 8.5% in Q2 2026, buying an estimated $39.9K and bringing the position to 19,518 shares worth $508K. The position accounts for 0.12% of the portfolio, ranked #109.

Gradient Capital Advisors first reported a position in IBDZ in Q3 2024 and has held it in 8 quarters since. 16 funds tracked by Wall St. Rank hold IBDZ as of Q2 2026.

  • Gradient Capital Advisors held 19,518 shares of iShares iBonds Dec 2034 Term Corporate ETF worth $508K as of Q2 2026.
  • Gradient Capital Advisors bought 1,532 iShares iBonds Dec 2034 Term Corporate ETF shares in Q2 2026, an estimated $39.9K.
  • iShares iBonds Dec 2034 Term Corporate ETF made up 0.12% of Gradient Capital Advisors's portfolio in Q2 2026, its #109 holding.
  • Gradient Capital Advisors first reported a position in iShares iBonds Dec 2034 Term Corporate ETF in Q3 2024 and has held it in 8 quarters since.
  • 16 funds tracked by Wall St. Rank held iShares iBonds Dec 2034 Term Corporate ETF as of Q2 2026.

Based on Gradient Capital Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.